References
- Abuzeid, M., Nassar, Z., Massaad, Z., Weiss, M., Ashraf, M., & Fakih, M. (2003). Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome. Human Reproduction, 18, 370–373. doi: https://doi.org/10.1093/humrep/deg074.
- Abuzeid, M., Warda, H., Joseph, S., Corrado, M.G., Abuzeid, Y., Ashraf, M., & Rizk, B. (2014). Outpatient management of severe ovarian hyperstimulation syndrome (OHSS) with placement of pigtail catheter. Facts Views and Vision in Obgyn, 6, 31–37. Retrieved from: http://www.fvvo.be/archive/volume-6/number-1/facts/outpatient-management-of-severe-ovarian-hyperstimulation-syndrome-with-placement-of-pigtail-catheter/.
- Bonilla-Musoles, F.M., Raga, F., Castillo, J.C., Sanz, M., Dolz, M., & Osborne, N. (2009). High doses of GnRH antagonists are efficient in the management of severe ovarian hyperstimulation syndrome. Clinical and Experimental Obstetrics and Gynecology, 36, 78–81. Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/19688946.
- Casals, G., Fábregues, F., Pavesi, M., Arroyo, V., & Balasch, J. (2013). Conservative medical treatment of ovarian hyperstimulation syndrome: A single center series and cost analysis study. Acta Obstetricaet Gynecologica Scandivanica, 92, 686–691. doi: https://doi.org/10.1111/aogs.12128.
- Csokmay, J.M., Yauger, B.J., Henne, M.B., Armstrong, A.Y., Queenan, J.T., & Segars, J.H. (2010). Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: “tap early and often” versus hospitalization. Fertility and Sterility, 93, 167–173. doi: https://doi.org/10.1016/j.fertnstert.2008.09.054.
- Delbaere, A., Bergmann, P.J., Gervy-Decoster, C., Staroukine, M., & Englert, Y. (1994). Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: Implications for pathophysiology and clinical management. Fertility and Sterility, 62, 731–737. doi: https://doi.org/10.1016/S0015-0282(16)56997-0.
- Delvigne, A., & Rosenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Human Reproduction Update, 8, 559–577. doi: https://doi.org/10.1093/humupd/8.6.559.
- Fluker, M.R., Copeland, J.E., & Yuzpe, A.A. (2000). An ounce of prevention: Outpatient management of the ovarian hyperstimulation syndrome. Fertility and Sterility, 73, 821–824. doi: https://doi.org/10.1016/S0015-0282(99)00606-8.
- Golan, A., Ron-El, R., & Herman, A. (1989). Ovarian hyperstimulation syndrome: An update review. Obstetrical and Gynecological Survey, 44, 430–440. Retrieved from http://journals.lww.com/obgynsurvey/Citation/1989/06000/Ovarian_Hyperstimulation_Syndrome__An_Update.4.aspx10.1097/00006254-198906000-00004.
- Gustofson, R.L., Browne, P., Van Nest, R.L., Richter, K.S., & Lasen, F.W. (2005). Aggressive outpatient management of severe ovarian hyperstimulation syndrome avoids complications and prolonged disease course. Fertility and Sterility, 84(Supp.1), S95. doi: https://doi.org/10.1016/j.fertnstert.2005.07.229.
- Hosseini, M.A., Mahdavi, A., Aleyasin, A., Safdarian, L., & Bahmaee, F. (2012). Treatment of ovarian hyperstimulation using gonadotropin releasing hormone antagonist: A pilot study. Gynaecological Endocrinology, 28, 853–855. doi: https://doi.org/10.3109/09513590.2012.683076.
- Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive. (2012). Ovarian Hyperstimulation Syndrome, Diagnosis and Management. Guideline No. 9.
- Lainas, G.T., Kolibianakis, E.M., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Tarlatzi, T.B., & Lainas, T.G. (2012). Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: An observational cohort study. Reproductive Biology and Endocrinology, 10, 69. doi: https://doi.org/10.1186/1477-7827-10-69.
- Lainas, G.T., Kolibianakis, E.M., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, T.G., & Tarlatzis, B.C. (2013). Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS. Human Reproduction, 28, 1929–1942. doi: https://doi.org/10.1093/humrep/det114.
- Lainas, G.T., Kolibianakis, E.M., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, T.G., & Tarlatzis, B.C. (2014). Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome. British Journal of Obstetrics and Gynaecology, 121, 848–855. doi: https://doi.org/10.1111/1471-0528.12572.
- Lainas, T.G., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, G.T., & Kolibianakis, E.M. (2007). Management of severe early ovarian hyperstimulation syndrome by reinitiation of GnRH antagonist. Reproductive Biomedicine Online, 15, 408–412. doi: https://doi.org/10.1016/S1472-6483(10)60366-5.
- Lainas, T.G., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, G.T., Iliadis, G.S., & Kolibianakis, E.M. (2009a). Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol. Reproductive Biomedicine Online, 18, 15–20. doi: https://doi.org/10.1016/S1472-6483(10)60419-1.
- Lainas, T.G., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, G.T., Alexopoulou, E., & Kolibianakis, E.M. (2009b). Live births after management of severe OHSS by GnRH antagonist administration in luteal phase. Reproductive Biomedicine Online, 19, 789–795. doi: https://doi.org/10.1016/j.rbmo.2009.09.021.
- Lincoln, S.R., Opsahl, M.S., Blauer, K.L., Black, S.H., & Schulman, J.D. (2002). Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization. Journal of Assisted Reproduction and Genetics, 19, 159–163. doi: https://doi.org/10.1023/A:1014828027282.
- Maslovitz, S., Jaffa, A., Eytan, O., Wolman, I., Many, A., Lessing, J.B., & Gamzu, R. (2004). Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstetrics and Gynaecology, 104, 321–326. doi: https://doi.org/10.1097/01.AOG.0000129956.97012.0d.
- Mathur, R., Evbuomwan, I., & Jenkins, J. (2005). Prevention and management of ovarian hyperstimulation syndrome. Obstetrics, Gynaecology and Reproductive Medicine, 15, 132–138. doi: https://doi.org/10.1016/j.curobgyn.2005.01.003.
- Nastri, C.O., Ferriani, R.A., Rocha, I.A., & Martins, W.P. (2010). Ovarian hyperstimulation syndrome: Pathophysiology and prevention. Journal of Assisted Reproduction and Genetics, 27, 121–128. doi: https://doi.org/10.1007/s10815-010-9387-6.
- Practice Committee of the American Society for Reproductive Medicine. (2016). Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: A guideline. Fertility and Sterility, 106, 1634–1647. doi: https://doi.org/10.1016/j.fertnstert.2016.08.048.
- Royal College of Obstetricians and Gynaecologists (RCOG). (2016). Ovarian hyperstimulation syndrome, management. Green-top Guideline No. 5. (First edition 2006; Third edition 2016). Royal College of Obstetrician and Gynaecologists. Retrieved from https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg5/.
- Shmorgun, D., Claman, P., Joint SOGC-CFAS Clinical Practice Guidelines Committee, Gysler, M., Hemmings, R., Cheung, A.P., … Young, D.C. (2011). The diagnosis and management of ovarian hyperstimulation syndrome, Joint SGOC and CFAS clinical practice guideline. Journal of Obstetrics and Gynaecology Canada, 33, 1156–1162. doi: https://doi.org/10.1016/S1701-2163(16)35085-X.
- Shrivastav, P., Nadkarni, P., & Craft, I. (1994). Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity. Human Reproduction, 9, 812–814. Retrieved from http://humrep.oxfordjournals.org/content/9/5/812.abstract10.1093/oxfordjournals.humrep.a138601.
- Shukla, U., Deval, B., Hamoda, H., Savvas, M., & Narvekar, N. (2011). Programme of outpatient surveillance for women at risk of severe OHSS following IVF: A prospective follow-up review of 99 cases. Human Fertility, 14(Suppl 1), 7. doi: https://doi.org/10.3109/14647273.2011.632962.
- Smith, L.P., Hacker, M.R., & Alper, M.M. (2009). Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis. Fertility and Sterility, 92, 1953–1910. doi: https://doi.org/10.1016/j.fertnstert.2008.09.011.
- Tan, B.K., & Mathur, R. (2013). Management of ovarian hyperstimulation syndrome. Produced on behalf of BFS Policy and Practice Committee. Human Fertility, 16, 151–159. doi: https://doi.org/10.3109/14647273.2013.788313.